Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $19.1 million.

  • Veracyte's Income from Continuing Operations rose 2633.35% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 42692.18%. This contributed to the annual value of $24.1 million for FY2024, which is 13244.18% up from last year.
  • Per Veracyte's latest filing, its Income from Continuing Operations stood at $19.1 million for Q3 2025, which was up 2633.35% from -$980000.0 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Income from Continuing Operations ranged from a high of $19.1 million in Q3 2025 and a low of -$41.9 million during Q1 2021
  • Its 5-year average for Income from Continuing Operations is -$7.2 million, with a median of -$8.4 million in 2023.
  • In the last 5 years, Veracyte's Income from Continuing Operations crashed by 63033.04% in 2023 and then surged by 47703.86% in 2025.
  • Over the past 5 years, Veracyte's Income from Continuing Operations (Quarter) stood at -$10.5 million in 2021, then soared by 63.16% to -$3.9 million in 2022, then plummeted by 630.33% to -$28.3 million in 2023, then surged by 118.16% to $5.1 million in 2024, then soared by 272.53% to $19.1 million in 2025.
  • Its last three reported values are $19.1 million in Q3 2025, -$980000.0 for Q2 2025, and $7.0 million during Q1 2025.